-
Top Picks For Chinese Medicine Brands By Oppenheimer
Tuesday, August 31, 2010 - 10:47amAmerican Oriental Bioengineering, Inc. (NYSE: AOB) is believed to have an important competitive advantage among Chinese drug manufacturers to wade through pricing uncertainties in healthcare reform, according to Oppenheimer. Stable drug CPIs help envision a positive outlook for OTC pharmaceuticals...
Read More >>
